Search for a clinical trial
Other search option(s)
8 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
rhLaman-08: A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis - AT
Institution: Information not provided - AT
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
rhLaman-08: 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis (Phase II) - FR
Institution: Information not provided - FR
GERMANY
Rheinland-Pfalz
MAINZ
rhLaman-08: A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis - DE
Universitätsmedizin Mainz
Zentrum für Kinder- und Jugendmedizin
ITALY
EMILIA ROMAGNA
PARMA
rhLaman-08: A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis - AT
Chiesi Farmaceutici S.p.A
CHIESI Farmaceutici S.p.A.
ITALY
EMILIA ROMAGNA
PARMA
rhLaman-08: A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis - DE
Chiesi Farmaceutici S.p.A
CHIESI Farmaceutici S.p.A.
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
A multi-center, un-controlled, open-labeled trial of the long-term safety of Lamazym aftercare treatment of subjects with alpha-Mannosidosis who previously participated in Lamazym-trials (Phase III) - FR
Institution: Information not provided - FR
Multinational clinical trial(s)
ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis
Institution: Information not provided - IT
DENMARK
Hovedstaden
COPENHAGEN